Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F8YVB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,226
Award facts
- Contract value 100% obligated
- $10,226.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $10,226.46 with an ultimate completion date of November 3, 2025, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract was competitively awarded without a set-aside designation under a firm fixed-price structure, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The SPE2DX vehicle functions as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contracting activity demonstrates substantial capability in fulfilling diverse medical supply requirements, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions with multiple award holders, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8YVB?
SPE2DR26F8YVB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26F8YVB worth?
The government has obligated $10,226 on SPE2DR26F8YVB.
Is contract SPE2DR26F8YVB an order under another contract?
Yes. SPE2DR26F8YVB is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YVB competed?
The extent of competition for SPE2DR26F8YVB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award